NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-201-1994-2-DE-09 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF DE EP 95927269.1 Abandoned
NCI E-201-1994-2-LU-17 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF LU EP 95927269.1 Abandoned
NCI E-201-1994-2-PT-20 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF PT EP 95927269.1 Abandoned
NCI E-201-1994-2-ES-11 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF ES EP 95927269.1 Abandoned
NCI E-201-1994-2-NL-19 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF NL EP 95927269.1 Abandoned
NCI E-201-1994-2-MC-18 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF MC EP 95927269.1 Abandoned
NCI E-201-1994-2-AT-06 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF AT EP 95927269.1 Abandoned
NCI E-201-1994-2-BE-07 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF BE EP 95927269.1 Abandoned
NCI E-201-1994-2-EP-04 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF EP National Stage 95927269.1 Abandoned
NCI E-200-1994-1-AU-02 MONOMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF AU National Stage 31969/95 Abandoned
NCI E-201-1994-2-AU-02 DIMERIC ARYLISOQUINOLINE ALKALOID COMPOUNDS AU National Stage 31351/95 Abandoned
NCI E-200-1994-1-PCT-01 MONOMERIC AND DIMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF PCT PCT COMB PCT/US1995/009132 Expired
NCI E-201-1994-2-PCT-01 DIMERIC ARYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF PCT PCT COMB PCT/US1995/009070 Expired
NCI E-200-1994-1-JP-05 MONOMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF JP National Stage 1996-505844 Abandoned
NCI E-201-1994-2-JP-05 MONOMERIC AND DIMERIC NAPHTHYLISOQUINOLINE ALKALOID AND SYNTHESIS METHODS THEREFORE JP National Stage 1996-505832 Abandoned
NCI E-200-1994-1-EP-06 MONOMERIC AND DIMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF EP DIV 03005979.4 Abandoned
NCI E-201-1994-2-CA-03 DIMERIC ARYLISOQUINOLINE ALKALOID AND SYNTHEISIS METHODS THEREOF CA National Stage 2195646 Abandoned
NCI E-200-1994-1-MC-15 MONOMERIC AND DIMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF MC EP 95928091.8 Abandoned
NIDDK E-052-2000-1-US-01 COMPOSITIONS HAVING NEUROPROTECTIVE AND ANALGESIC ACTIVITY US CIP 08/502,468 Abandoned
NIAID E-040-1994-2-US-01 ATTENUATED HUMAN ROTAVIRUS VACCINE US CIP 08/500,564 7150984 Abandoned PDF
NIAID E-040-1994-3-PCT-01 ATTENUATED HUMAN ROTAVIRUS VACCINE PCT PCT COMB PCT/US1995/008665 Expired
NCI E-200-1990-4-US-01 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) US ORD 08/500,306 6165460 Expired PDF
NHLBI E-177-1994-0-PCT-02 USE OF SWINHOLIDE A FOR SEVERING AND DEPOLYMERIZING ACTIN PCT PCT PCT/US1995/008610 Expired
NCI E-130-1993-0-CA-04 METHODS OF DELIVERING AGENTS TO TARGET CELLS CA National Stage 2153568 Abandoned
NCI E-232-1995-0-AU-03 METHODS OF IDENTIFYING PATIENTS HAVING ALTERED IMMUNE STATUS AU National Stage 29997/95 Abandoned
NCI E-232-1995-0-PCT-02 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS PCT PCT PCT/US1995/008224 Expired
NCI E-232-1995-0-JP-06 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS JP National Stage 1996-505745 Abandoned
NCI E-232-1995-0-EP-05 METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS EP National Stage 95926135.5 Abandoned
NHLBI E-176-1995-0-US-01 METHOD OF IDENTIFYING INHIBITORS OF THE JAK-STAT SIGNAL TRANSDUCTION PATHWAY US 60/000,971 Abandoned
NCI E-232-1995-0-CA-04 EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION CA National Stage 2195217 Abandoned
NIDCR E-141-1993-0-EP-03 POLYPEPTIDES USEFUL FOR TREATING INFLAMMATORY DISORDERS EP National Stage 94903455.7 Abandoned
NCI E-136-1994-0-AU-04 BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER AU National Stage 29059/95 Abandoned
NCI E-136-1994-0-PCT-02 NEW BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER PCT PCT PCT/US1995/007854 Expired
NCI E-136-1994-0-JP-06 BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER JP National Stage 1996-503293 Abandoned
NCI E-136-1994-0-EP-03 BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER EP National Stage 95924630.7 Abandoned
NCI E-136-1994-0-CA-05 BREFELDIN A DERIVATIVES AND THEIR UTILITY IN THE TREATMENT OF CANCER CA National Stage 2193704 Abandoned
NCI E-080-1995-0-US-01 COMPUTATIONAL ANALYSIS OF NUCLEIC ACID INFORMATION DEFINES BINDING SITES US ORD 08/494,115 5867402 Expired PDF
NCI E-165-1995-0-US-01 DEPIGMENTING ACTIVITY OF AGOUTI SIGNAL PROTEIN AND PEPTIDES THEREOF US 60/000,436 Abandoned
NHGRI E-170-1995-1-US-01 Mutated Proteins Associated with Ataxia-Telangiectasia (as amended) US CIP 08/493,092 5728807 Expired PDF
NIDA E-078-1995-0-US-01 4' AND 4',4 -SUBSTITUTED-3a-(DIPHENYLMETHOXY)TROPANE ANALOGS AS COCAINE THERAPEUTICS US 60/000,378 Abandoned
NCI E-127-1994-0-GB-04 Defects in Drug Metabolism GB National Stage 9626479.1 Abandoned
NCI E-204-1994-0-US-01 CHEMOTACTIC AGENTS FOR T-CELLS US ORD 08/491,204 5837247 Expired PDF
NCI E-127-1994-0-PCT-02 Defects in Drug Metabolism PCT PCT PCT/US1995/007605 Expired
NIDDK E-122-1989-0-JP-07 5-AMINOCARBONYL -5H-DIBENZO(A.D.) CYCLOHEPTEN-5, 10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION JP DIV 1995-146525 Abandoned
NHLBI E-065-1995-0-PCT-02 NOVEL RETROVIRAL ENVELOPE AND LTR AND RETROVIRAL VECTOR PARTICLES INCLUDING SUCH ENVELOPE AND/OR LTR PCT PCT PCT/US1995/007385 Abandoned
NCI E-317-1984-17-US-02 Cloned DNA Sequences Related To The Genomic RNA Of Lymphadenopathy-Associated Virus (LAV) And Proteins Encoded By Said LAV Genomic RNA US CON 08/475,822 7205102 Expired PDF
NCI E-306-1987-1-US-01 METHOD FOR TREATING MALIGNANCY AND AUTOIMMUNE DISORDERS IN HUMANS US CIP 08/478,748 7094404 Abandoned PDF
NCI E-148-2007-2-US-08 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses US DIV 08/472,928 7078516 Expired PDF
NCI E-149-1995-0-US-01 Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (KGF) US CON 08/477,983 7026291 Expired PDF
NIDCR E-058-1993-3-US-01 INHIBITION OF RETROVIRUS INFECTION US CIP 08/485,438 6869925 Expired PDF